학술논문
'학술논문'
에서 검색결과 10,717건 | 목록
1~20
Academic Journal
Pennesi, E; Brivio, E; Ammerlaan, ACJ; Jiang, Y; Van der Velden, VHJ; Beverloo, HB; Sleight, B; Locatelli, F; Brethon, B; Rossig, C; Engstler, G; Nilsson, A; Bruno, B; Petit, A; Bielorai, B; Rizzari, C; Rialland, F; Rubio-San-Simón, A; Sirvent, FJB; Diaz-de-Heredia, C; Rives, S; Zwaan, CM
Haematologica. 109(10):3157-3166
Academic Journal
Alborzian Deh Sheikh, Amin ; Long, Wang ; Matsubara, Naoko ; Futamura, Takeshi ; Imamura, Akihiro ; Ando, Hiromune ; Ohno, Shiho ; Abdu-Allah, Hajjaj H.M. ; Takematsu, Hiromu ; Asano, Masatake ; Yamaguchi, Yoshiki ; Ishida, Hideharu ; Tsubata, Takeshi
In Carbohydrate Research August 2025 554
Report
A Phase 2 Study of Inotuzumab Ozogamicin (NSC# 772518) in Children and Young Adults With Relapsed or Refractory CD22 + B-Acute Lymphoblastic Leukemia (B-ALL)
Shi Z, Zhu Y, Zhang J, Chen B. Monoclonal antibodies: new chance in the management of B-cell acute lymphoblastic leukemia. Hematology. 2022 Dec;27(1):642-652. doi: 10.1080/16078454.2022.2074704.
O'Brien MM, Ji L, Shah NN, Rheingold SR, Bhojwani D, Yuan CM, Xu X, Yi JS, Harris AC, Brown PA, Borowitz MJ, Militano O, Kairalla J, Devidas M, Raetz EA, Gore L, Loh ML. Phase II Trial of Inotuzumab Ozogamicin in Children and Adolescents With Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia: Children's Oncology Group Protocol AALL1621. J Clin Oncol. 2022 Mar 20;40(9):956-967. doi: 10.1200/JCO.21.01693. Epub 2022 Jan 10.
Shi Z, Zhu Y, Zhang J, Chen B. Monoclonal antibodies: new chance in the management of B-cell acute lymphoblastic leukemia. Hematology. 2022 Dec;27(1):642-652. doi: 10.1080/16078454.2022.2074704.
O'Brien MM, Ji L, Shah NN, Rheingold SR, Bhojwani D, Yuan CM, Xu X, Yi JS, Harris AC, Brown PA, Borowitz MJ, Militano O, Kairalla J, Devidas M, Raetz EA, Gore L, Loh ML. Phase II Trial of Inotuzumab Ozogamicin in Children and Adolescents With Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia: Children's Oncology Group Protocol AALL1621. J Clin Oncol. 2022 Mar 20;40(9):956-967. doi: 10.1200/JCO.21.01693. Epub 2022 Jan 10.
Report
Inotuzumab Ozogamicin for Children With MRD Positive CD22 + Lymphoblastic Leukemia
Shi Z, Zhu Y, Zhang J, Chen B. Monoclonal antibodies: new chance in the management of B-cell acute lymphoblastic leukemia. Hematology. 2022 Dec;27(1):642-652. doi: 10.1080/16078454.2022.2074704.
Shi Z, Zhu Y, Zhang J, Chen B. Monoclonal antibodies: new chance in the management of B-cell acute lymphoblastic leukemia. Hematology. 2022 Dec;27(1):642-652. doi: 10.1080/16078454.2022.2074704.
Report
Pediatric and Young Adult Leukemia Adoptive Therapy (PLAT)-04: A Phase 1 Feasibility and Safety Study of CD22 -CAR T Cell Immunotherapy for CD22 + Leukemia and Lymphoma
Report
Phase I/Ib Clinical Trial of Autologous CD22 Chimeric Antigen Receptor (CAR) T Cells Following Commercial CD19 CAR T Cells in Children and Young Adults With Recurrent or Refractory B Cell Malignancies
Report
Phase I/Ib Clinical Trial of Autologous CD22 Chimeric Antigen Receptor (CAR) T Cells in Adults With Recurrent or Refractory B Cell Malignancies
Baird JH, Frank MJ, Craig J, Patel S, Spiegel JY, Sahaf B, Oak JS, Younes SF, Ozawa MG, Yang E, Natkunam Y, Tamaresis J, Ehlinger Z, Reynolds WD, Arai S, Johnston L, Lowsky R, Meyer E, Negrin RS, Rezvani AR, Shiraz P, Sidana S, Weng WK, Davis KL, Ramakrishna S, Schultz L, Mullins C, Jacob A, Kirsch I, Feldman SA, Mackall CL, Miklos DB, Muffly L.CD22 -directed CAR T-cell therapy induces complete remissions in CD19-directed CAR-refractory large B-cell lymphoma. Blood. 2021 Apr 29;137(17):2321-2325. doi: 10.1182/blood.2020009432.
Baird JH, Frank MJ, Craig J, Patel S, Spiegel JY, Sahaf B, Oak JS, Younes SF, Ozawa MG, Yang E, Natkunam Y, Tamaresis J, Ehlinger Z, Reynolds WD, Arai S, Johnston L, Lowsky R, Meyer E, Negrin RS, Rezvani AR, Shiraz P, Sidana S, Weng WK, Davis KL, Ramakrishna S, Schultz L, Mullins C, Jacob A, Kirsch I, Feldman SA, Mackall CL, Miklos DB, Muffly L.
Report
Immunotherapy with CD19+CD22 CAR Redirected T-cells for High Risk/relapsed Paediatric CD19+ and CD22 + Acute Lymphoblastic Leukaemia
Ghorashian S, Kramer AM, Onuoha S, Wright G, Bartram J, Richardson R, Albon SJ, Casanovas-Company J, Castro F, Popova B, Villanueva K, Yeung J, Vetharoy W, Guvenel A, Wawrzyniecka PA, Mekkaoui L, Cheung GW, Pinner D, Chu J, Lucchini G, Silva J, Ciocarlie O, Lazareva A, Inglott S, Gilmour KC, Ahsan G, Ferrari M, Manzoor S, Champion K, Brooks T, Lopes A, Hackshaw A, Farzaneh F, Chiesa R, Rao K, Bonney D, Samarasinghe S, Goulden N, Vora A, Veys P, Hough R, Wynn R, Pule MA, Amrolia PJ. Enhanced CAR T cell expansion and prolonged persistence in pediatric patients with ALL treated with a low-affinity CD19 CAR. Nat Med. 2019 Sep;25(9):1408-1414. doi: 10.1038/s41591-019-0549-5. Epub 2019 Sep 2.
Ghorashian S, Kramer AM, Onuoha S, Wright G, Bartram J, Richardson R, Albon SJ, Casanovas-Company J, Castro F, Popova B, Villanueva K, Yeung J, Vetharoy W, Guvenel A, Wawrzyniecka PA, Mekkaoui L, Cheung GW, Pinner D, Chu J, Lucchini G, Silva J, Ciocarlie O, Lazareva A, Inglott S, Gilmour KC, Ahsan G, Ferrari M, Manzoor S, Champion K, Brooks T, Lopes A, Hackshaw A, Farzaneh F, Chiesa R, Rao K, Bonney D, Samarasinghe S, Goulden N, Vora A, Veys P, Hough R, Wynn R, Pule MA, Amrolia PJ. Enhanced CAR T cell expansion and prolonged persistence in pediatric patients with ALL treated with a low-affinity CD19 CAR. Nat Med. 2019 Sep;25(9):1408-1414. doi: 10.1038/s41591-019-0549-5. Epub 2019 Sep 2.
Report
Open Label Dose-escalation and Dose-expansion Study to Evaluate the Safety, Expansion, Persistence and Clinical Activity of UCART22 (Allogeneic Engineered T-cells Expressing Anti-CD22 Chimeric Antigen Receptor) in Patients With Relapsed or refractoryCD22+ B-cell Acute Lymphoblastic Leukemia (B-ALL)
Academic Journal
Enkhbayar, Bayarmaa ; Lu, Shao-Chia ; Tsai, Ho-Yang ; Liang, Suh-Yuen ; Wu, Shang-Ju ; Lin, Kuo-I ; Angata, Takashi
In Journal of Biological Chemistry April 2025 301(4)
Academic Journal
Zhang, Wenjun; Han, Yali; Huang, Huachen; Su, Yue; Ren, Honglei; Qi, Caiyun; Li, Jinyi; Yang, Huaijin; Xu, Jing; Chang, Guoqiang; Qiu, Wenjin; Liu, Qiang; Chang, Ting
Journal of Neuroinflammation. 21(1)
Academic Journal
Report
Pilot Study of Autologous Anti-CD22 Chimeric Antigen Receptor Redirected T Cells in Pediatric Patients With Chemotherapy Resistant Or Refractory Acute Lymphoblastic Leukemia
Singh N, Frey NV, Engels B, Barrett DM, Shestova O, Ravikumar P, Cummins KD, Lee YG, Pajarillo R, Chun I, Shyu A, Highfill SL, Price A, Zhao L, Peng L, Granda B, Ramones M, Lu XM, Christian DA, Perazzelli J, Lacey SF, Roy NH, Burkhardt JK, Colomb F, Damra M, Abdel-Mohsen M, Liu T, Liu D, Standley DM, Young RM, Brogdon JL, Grupp SA, June CH, Maude SL, Gill S, Ruella M. Antigen-independent activation enhances the efficacy of 4-1BB-costimulatedCD22 CAR T cells. Nat Med. 2021 May;27(5):842-850. doi: 10.1038/s41591-021-01326-5. Epub 2021 Apr 22.
Singh N, Frey NV, Engels B, Barrett DM, Shestova O, Ravikumar P, Cummins KD, Lee YG, Pajarillo R, Chun I, Shyu A, Highfill SL, Price A, Zhao L, Peng L, Granda B, Ramones M, Lu XM, Christian DA, Perazzelli J, Lacey SF, Roy NH, Burkhardt JK, Colomb F, Damra M, Abdel-Mohsen M, Liu T, Liu D, Standley DM, Young RM, Brogdon JL, Grupp SA, June CH, Maude SL, Gill S, Ruella M. Antigen-independent activation enhances the efficacy of 4-1BB-costimulated
Report
Clinical Study of Novel TLR2-Containing CAR-T Cells Targeting CD19 and CD22 for Refractory/Relapsed B-Cell Acute Lymphoblastic Leukemia and Non-Hodgkin Lymphoma
Academic Journal
Dreyzin, A.; Shao, L.; Cai, Y.; Han, K.L.; Prochazkova, M.; Shi, R.; Martin, K.; Highfill, S.; Stroncek, D.; Jin, P.; Yates, B.; Taylor, N.; Shah, N.N.; Gertz, M.; O'Neill, M.; Andresson, T.
In: Molecular Therapy . (Molecular Therapy, 2 July 2025, 33(7):3360-3374)
Academic Journal
Wang, Hanyu; Wang, Gaoxiang; Li, Tongjuan; Zhang, Peiling; Mao, Zekai; Luo, Hui; Zhu, Xiaojian; Li, Dengju; Zhou, Jianfeng; Zhou, Xiaoxi; Huang, Liang
Academic Journal
Report
Pediatric and Young Adult Leukemia Adoptive Therapy (PLAT)-07: A Phase 1/2 Study of CD22 -Specific CAR T Cells for CD22 + Leukemia or Lymphoma
Academic Journal
Escherich, Carolin S. ; Li, Zhenhua ; Barnett, Kelly R. ; Li, Yizhen ; Walker, Megan ; Yoshimura, Satoshi ; Yang, Wenjian ; Huang, Xin ; Yu, Jiyang ; Stock, Wendy ; Paietta, Elisabeth ; Konopleva, Marina Y. ; Kornblau, Steven M. ; Jabbour, Elias ; Litzow, Mark R. ; Inaba, Hiroto ; Pui, Ching-Hon ; Loh, Mignon L. ; Evans, William E. ; Savic, Daniel ; Yang, Jun J.
In Blood 24 July 2025 146(4):471-481
Academic Journal
Akatsu, Chizuru ; Naito-Matsui, Yuko ; Abdu-Allah, Hajjaj H.M. ; Imamura, Akihiro ; Long, Wang ; Ishida, Hideharu ; Takematsu, Hiromu ; Tsubata, Takeshi
In Journal of Biological Chemistry September 2024 300(9)
검색 결과 제한하기
제한된 항목
[검색어] CD22
발행연도 제한
-
학술DB(Database Provider)
저널명(출판물, Title)
출판사(Publisher)
자료유형(Source Type)
주제어
언어